The Impact of Substance Use on Mother-to-child Transmission of HIV
Attributes to meet: PDF: Download File, Reports
Download File: condition met
Report, 2012
This literature review aimed to assess the impact of substance use on mother-to-child transmission (MTCT) of HIV. Such a review was deemed necessary due to Saskatchewan’s unique HIV profile. Specifically, new cases of HIV in Saskatchewan are: (a) the highest in Canada; (b) most often associated with injection drug use (IDU); and (c) increasing rapidly in women of childbearing age (ages 15 to 39). The primary questions addressed in the report include: Why do substance use services need to be focused on to avoid MTCT of HIV? How does having a substance use issue influence high risk behaviours that can lead to HIV infection? How does having a substance use issue affect virus progression and impact the health of pregnant women living with HIV?
Related products
-
Provincial Services for Women Living with HIV Who Have Experienced Violence and Abuse
Report, 2012
This document outlines agencies (provincial and national) that provide services for women who have experienced abuse, sexual abuse, and/or have HIV. Descriptions and contact information (phone numbers and websites) are provided.
SKU: 7-512 -
HIV, Pregnancy, and Tobacco Use
Poster, 2023
This poster explains that for women living with HIV, smoking tobacco during pregnancy can increase the chances that HIV will be passed to the baby. Supports are listed to help pregnant women and those planning a pregnancy to quit or reduce their tobacco use.
SKU: 7-517 -
Substance Use, Pregnancy, and HIV/AIDS: Treatment Programs for Pregnant Women
Report, 2012
This living document identifies existing substance use treatment programs and services available to pregnant women and pregnant women living with HIV/AIDS in North America, with a particular focus on Saskatchewan. The information provided through the current environmental scan is useful both for pregnant women who use substances who are seeking services, and for healthcare professionals, who can use this information to assist women in accessing services that are appropriate to their needs. Ideally, this would be done as part of a multidisciplinary team, where the referring professional continues to be involved in the care of the woman. It is hoped that the information provided will increase awareness of the existing substance use treatment centres and programs for pregnant women, with the goal of potentially increasing referrals to and use of these programs.
SKU: 7-509 -
Edinburgh Postpartum Depression Scale (EPDS) Screening and Care Guide
Guide and Manual, 2012
The EPDS Screening and Care Guide provides healthcare providers with score interpretation and care guide to use when screening pregnant and postpartum women for depression and anxiety using the Edinburgh Postpartum Depression Scale (EPDS). It also includes guidelines for medical management when maternal mental health is of concern, contact information for Saskatchewan Healthline and Saskatchewan Drug Information Services, and a space for relevant local contact information. On the reverse side of the form there is a brief description of maternal depression including common symptoms, guidelines for screening, and the EPDS questions.
* For an updated version of the Maternal Mental Health Edinburgh Postnatal Depression Scale (EPDS) Screening and Care Guide available through the Saskatchewan Ministry of Health, please visit https://www.ehealthsask.ca/services/resources/Resources/EPDS-screening-2019.pdfSKU: 2-104